Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( <scp>INTEGUMENT</scp> ‐ <scp>PED</scp> ): A Phase 3 Randomized Controlled Trial

Authors

Institutions

Publication Details

Journal
Pediatric Dermatology
Published
2025-02-20
DOI
https://doi.org/10.1111/pde.15840
Citations
6
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
12.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( INTEGUMENT ‐ PED ): A Phase 3 Randomized Controlled Trial

Rocco Serrao, Tracy Funk, Robert Higham, Eric L. Simpson et al.
6 citations
Pediatric Dermatology
Dermatology and Skin Diseases
12.03
article

Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( INTEGUMENT ‐ PED ): A Phase 3 Randomized Controlled Trial

Rocco Serrao, Tracy Funk, Robert Higham, Eric L. Simpson, Scott Snyder, Patrick Burnett, Mark S. Lee, Mark Boguniewicz, Vimal H. Prajapati, Melissa S. Seal, Lawrence F. Eichenfield, Diane T. Hanna, Adelaide A. Hebert, Mercedes E. González, David H. Chu, David R. Berk, David Krupa, Lisa Swanson, Joseph Browning
article en
6 citations

Abstract

No abstract available for this paper.
Pediatric DermatologyVol. 42(2)
Oregon Health & Science University (US), University of Calgary (CA), National Jewish Health (US), University of California San Diego (US), Rady Children's Hospital-San Diego (US), Texas Dermatology and Laser Specialists (US), Probity Medical Research (CA), Progressive Clinical Research (US), Atara Biotherapeutics (United States) (US), The University of Texas Health Science Center at Houston (US), University of Colorado Denver (US)
Openalex Percentile: Top 2%
Dermatology and Skin Diseases
12.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( <scp>INTEGUMENT</scp> ‐ <scp>PED</scp> ): A Phase 3 Randomized Controlled Trial — Rocco Serrao, Tracy Funk, et al. · Pediatric Dermatology (2025) | TGRS Research Map | TGRS